LATEST NEWS

Xilinx Spartan-7 FPGAs Now in Production

Today announced that its Spartan®-7 family of FPGAs is now available for order and shipping to standard lead times. As a key member of Xilinx’s Cost-Optimized Portfolio, this device family is designed to meet the needs of cost-sensitive markets by delivering low cost and low power entry points that are I/O optimized for connectivity with industry leading performance-per-watt.

Available in small form factor packaging, Spartan-7 FPGAs offer expanded temperature ranges of –40° to +125°C in commercial devices. The Spartan-7 family also offers enhanced processor scalability at lower cost entry points, with 50 percent higher embedded performance than previous generations using Xilinx® 32-bit MicroBlaze™ soft processor IP.  Spartan-7 devices also offer a layered security solution with AES-256 bitstream decryption, SHA-256 bitstream authentication, and on-chip eFUSE key storage.

Now for the first time, Spartan FPGA-based designs can take advantage of the Vivado® Design Suite, giving users even more productivity advantages. All Spartan-7 FPGAs are supported by the no-cost Vivado® HL WebPACK™ Edition, as well as the Vivado HL Design and System Editions.

Liat

Recent Posts

Tower Semiconductor Secures $1.3 Billion Silicon Photonics Agreements and Reports Strong Q1 2026 Growth

Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…

3 days ago

14 Israeli Cybersecurity Companies Named to the Rising in Cyber 2026 List of the World’s Most Promising Cyber Startups

The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…

3 days ago

Sequent Selected by 15 Canadian Municipalities to Deliver Verifiable, Trust-Based Digital Voting for Elections

More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…

3 days ago

Sheba and Ichilov Medical Centers Join AccuLine’s International Clinical Trial for AI-Driven Early Heart Attack Risk Assessment

The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…

3 days ago

Molex Completes Acquisition of Teramount Ltd.

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…

6 days ago

Immunai Expands Oncology Collaboration, Extending AI-Driven Biomarker and Clinical Insights Through 2027

This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…

6 days ago